Lunai Bioworks (RENB)
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment of cance...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 1.420
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 17.552
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- benzinga_article · Apr 7 at 05:05 PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
- prnewswire · Mar 30 at 01:02 PM
09:00 ETDelonix Bioworks Announces Initiation of Phase 1 First-in-Human Clinical Trial of a Next-Generation MenB OMV Vaccine DX-104
- TradingView · Feb 17 at 08:21 PM
Lunai Bioworks Inc. SEC 10-Q Report
- Unusual Whales · Feb 6 at 12:33 PM
Delonix Bioworks clears IND for DX-104 vaccine in China & Australia for MenB; Feb 6, 2026.
- Unusual Whales · Dec 9, 2025 at 12:46 PM
Lunai Bioworks discovers 3 Parkinson's subtypes, targets for $13B market. Exciting progress in precision therapeutics.
